Skip to main content
Home
Body
facebook instagram linkedin

Donate now

Main navigation

  • Patients & Caregivers
  • Mesothelioma Health Network
  • Resources
  • News & Events
  • Donate
  • About the CMF

User account menu

  • Membership
  • Log in

Secondary menu

Staff menu

United States & International

United States

  • American Society of Clinical Oncology (ASCO)
    • ASCO Guidelines
    • ASCO Guideline – Treatment of Malignant Pleural Mesothelioma
  • American Society for Radiation Oncology (ASTRO)
    • ASTRO Clinical Practice Guidelines 
  • US National Comprehensive Cancer Network (NCCN)
    • NCCN Clinical Practice Guidelines in Oncology
    • Malignant Pleural Mesothelioma (NCCN Guideline with NCCN Evidence Block)
    • Malignant Pleural Mesothelioma – NCCN Guideline
    • International Adaptations and Translations of the NCCN Clinical Practice Guidelines in Oncology
    • Malignant Pleural Mesothelioma – NCCN Guideline (Japanese translation)
    • NCCN Mobile Apps for Smartphones and Tablets
  • US National Cancer Institute
    • Physician Data Query (PDQ ® ) Cancer Information Summaries
    • Malignant Mesothelioma Treatment (PDQ®)–Health Professional Version

 

United Kingdom

  • National Institute for Health and Clinical Excellence (NICE)
    • NICE Guidance documents
    • Pemetrexed for the treatment of malignant pleural mesothelioma

 

European Union

  • European Society for Medical Oncology (ESMO)
    • ESMO Clinical Practice Guidelines
    • Malignant Pleural Mesothelioma: ESMO Clinical Practice Guidelines
    • ESMO Pocket Guidelines & Mobile App (Android and iOS compatible)
Body
Contact Us
Body
By mail:
4302-50 Yorkville Ave.
Toronto, Ontario
M4W 0A3
 
Privacy Policy
Body
By email:
info@cmfonline.org
Body
By cell:
416-417-5544